FibroBiologics, Inc. Common StockFBLGNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+160.2%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+160.2%/yr
Quarterly compound
Percentile
P100
Near historical high
vs 3Y Ago
17.6x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 48.59% |
| Q3 2025 | -12.20% |
| Q2 2025 | 0.90% |
| Q1 2025 | -22.06% |
| Q4 2024 | -10.74% |
| Q3 2024 | -3.97% |
| Q2 2024 | 6.55% |
| Q1 2024 | -39.11% |
| Q4 2023 | -20.86% |
| Q3 2023 | 1.96% |
| Q2 2023 | 7.59% |
| Q1 2023 | -73.70% |
| Q4 2022 | 2.76% |
| Q3 2022 | -47.20% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |